Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit-a mechanism of relevance to resistant depression?

PeerJ

Volumn 2016, Issue 2, 2016, Pages

  Wong, Jing J ^a   O'Daly, Owen ^a   Mehta, Mitul A ^a   Young, Allan H ^a   Stone, James M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anterior cingulate; Antidepressant; Depression; Ketamine; MRI

Indexed keywords

KETAMINE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BOLD SIGNAL; BRAIN FUNCTION; CONNECTOME; DORSAL ANTERIOR CINGULATE CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; INFUSION; MALE; MEMORY; NORMAL HUMAN; RESTING STATE NETWORK; RETROSPLENIAL CORTEX; THALAMUS; TREATMENT RESISTANT DEPRESSION;

EID: 84963959572     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.1710     Document Type: Article

References (34)

1. Baeken C, Marinazzo D, Wu GR, Van Schuerbeek P, De Mey J, Marchetti I, Vanderhasselt MA, Remue J, Luypaert R, De Raedt R. 2014. Accelerated HF-rTMS in treatment-resistant unipolar depression: insights from subgenual anterior cingulate functional connectivity. World Journal of Biological Psychiatry 15:286-297 DOI 10.3109/15622975.2013.872295.
2. Davey CG, Harrison BJ, Yucel M, Allen NB. 2012. Regionally specific alterations in functional connectivity of the anterior cingulate cortex in major depressive disorder. Psychological Medicine 42:2071-2081 DOI 10.1017/S0033291712000323.
3. Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM. 2008. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Archives of General Psychiatry 65:154-164 DOI 10.1001/archgenpsychiatry.2007.37.
4. De Simoni S, Schwarz AJ, O'Daly OG, Marquand AF, Brittain C, Gonzales C, Stephenson S, Williams SC, Mehta MA. 2013. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers. NeuroImage 64:75-90 DOI 10.1016/j.neuroimage.2012.09.037.
5. Disner SG, Beevers CG, Haigh EA, Beck AT. 2011. Neural mechanisms of the cognitive model of depression. Nature Reviews Neuroscience 12:467-477 DOI 10.1038/nrn3027.
6. Doyle OM, De Simoni S, Schwarz AJ, Brittain C, O'Daly OG, Williams SC, Mehta MA. 2013. Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents. The Journal of Pharmacology and Experimental Therapeutics 345:151-160 DOI 10.1124/jpet.112.201665.
7. Drevets WC, Savitz J, Trimble M. 2008. The subgenual anterior cingulate cortex in mood disorders. CNS Spectrums 13:663-681.
8. Fond G, Loundou A, Rabu C, Macgregor A, Lancon C, Brittner M, Micoulaud-Franchi JA, Richieri R, Courtet P, Abbar M, Roger M, Leboyer M, Boyer L. 2014. Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology 231:3663-3676 DOI 10.1007/s00213-014-3664-5.
9. Gass N, Schwarz AJ, Sartorius A, Schenker E, Risterucci C, Spedding M, Zheng L, Meyer-Lindenberg A, Weber-Fahr W. 2014. Sub-anesthetic ketamine modulates intrinsic BOLD connectivity within the hippocampal-prefrontal circuit in the rat. Neuropsychopharmacology 39:895-906 DOI 10.1038/npp.2013.290.
10. Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, Reiss AL, Schatzberg AF. 2007. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry 62:429-437 DOI 10.1016/j.biopsych.2006.09.020.
11. Grimm O, Gass N, Weber-Fahr W, Sartorius A, Schenker E, Spedding M, Risterucci C, Schweiger JI, Bohringer A, Zang Z, Tost H, Schwarz AJ, Meyer-Lindenberg A. 2015. Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats. Psychopharmacology 232:4231-4241 DOI 10.1007/s00213-015-4022-y.
12. Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM. 2011. The subcallosal cingulate gyrus in the context of major depression. Biological Psychiatry 69:301-308 DOI 10.1016/j.biopsych.2010.09.034.
13. Hamilton JP, Farmer M, Fogelman P, Gotlib IH. 2015. Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience. Biological Psychiatry 78(4):224-230 DOI 10.1016/j.biopsych.2015.02.020.
14. Joules R, Doyle OM, Schwarz AJ, O'Daly OG, Brammer M, Williams SC, Mehta MA. 2015. Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile. Psychopharmacology 232:4205-4218 DOI 10.1007/s00213-015-3951-9.
15. Konarski JZ, Kennedy SH, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS. 2009. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of Psychiatry and Neuroscience 34:175-180.
16. Lindenmayer JP, Bernstein-Hyman R, Grochowski S. 1994. A new five factor model of schizophrenia. Psychiatric Quarterly 65:299-322 DOI 10.1007/BF02354306.
17. Ma Q, Zeng LL, Shen H, Liu L, Hu D. 2013. Altered cerebellar-cerebral resting-state functional connectivity reliably identifies major depressive disorder. Brain Research 1495:86-94 DOI 10.1016/j.brainres.2012.12.002.
18. Maletic V, Raison CL. 2009. Neurobiology of depression, fibromyalgia and neuropathic pain. Frontiers in Bioscience 14:5291-5338 DOI 10.2741/3598.
19. Malykhin NV, Coupland NJ. 2015. Hippocampal neuroplasticity in major depressive disorder. Neuroscience 309:200-213 DOI 10.1016/j.neuroscience.2015.04.047.
20. Miller CH, Hamilton JP, Sacchet MD, Gotlib IH. 2015. Meta-analysis of Functional Neuroimaging of Major Depressive Disorder in Youth. JAMA Psychiatry 72:1045-1053 DOI 10.1001/jamapsychiatry.2015.1376.
21. Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Drevets WC, Zarate Jr CA. 2014. Neural correlates of rapid antide-pressant response to ketamine in bipolar disorder. Bipolar Disorders 16:119-128 DOI 10.1111/bdi.12118.
22. Papakostas GI, Fava M. 2010. Pharmacotherapy for depression and treatment-resistant depression. Hackensack: World Scientific.
23. Salvadore G, Cornwell BR, Colon-Rosario V, Coppola R, Grillon C, Zarate Jr CA, Manji HK. 2009. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biological Psychiatry 65:289-295 DOI 10.1016/j.biopsych.2008.08.014.
24. Scheidegger M, Walter M, Lehmann M, Metzger C, Grimm S, Boeker H, Boesiger P, Henning A, Seifritz E. 2012. Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. PLoS ONE 7:e44799 DOI 10.1371/journal.pone.0044799.
25. Sheline YI, Price JL, Yan Z, Mintun MA. 2010. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proceedings of the National Academy of Sciences of the United States of America 107:11020-11025 DOI 10.1073/pnas.1000446107.
26. Siegle GJ, Thompson WK, Collier A, Berman SR, Feldmiller J, Thase ME, Friedman ES. 2012. Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Archives of General Psychiatry 69:913-924 DOI 10.1001/archgenpsychiatry.2012.65.
27. Song XW, Dong ZY, Long XY, Li SF, Zuo XN, Zhu CZ, He Y, Yan CG, Zang YF. 2011. REST: a toolkit for resting-state functional magnetic resonance imaging data processing. PLoS ONE 6:e25031 DOI 10.1371/journal.pone.0025031.
28. Stone J, Kotoula V, Dietrich C, De Simoni S, Krystal JH, Mehta MA. 2015. Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe. Journal of Psychopharmacology 29:1025-1028 DOI 10.1177/0269881115592337.
29. Sundermann B, Olde Lütke Beverborg Mona, Pfleiderer Bettina. 2014. Towards literature-based feature selection for diagnostic classification: a meta-analysis of resting-state fMRI in depression. Frontiers in Human Neuroscience 8:692 DOI 10.3389/fnhum.2014.00692.
30. Taylor SF, Liberzon I. 2007. Neural correlates of emotion regulation in psychopathology. Trends in Cognitive Sciences 11:413-418 DOI 10.1016/j.tics.2007.08.006.
31. Yakovlev P, Locke S, KoskoffD, Patton R. 1960. Limbic nuclei of thalamus and connections of limbic cortex. Archives of Neurology 3:620-641 DOI 10.1001/archneur.1960.00450060008002.
32. Young KA, Holcomb LA, Yazdani U, Hicks PB, German DC. 2004. Elevated neuron number in the limbic thalamus in major depression. American Journal of Psychiatry 161:1270-1277 DOI 10.1176/appi.ajp.161.7.1270.
33. Zarate Jr CA, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA. 2012. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biological Psychiatry 71:939-946 DOI 10.1016/j.biopsych.2011.12.010.
34. Zarate Jr CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. 2006. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 63:856-864 DOI 10.1001/archpsyc.63.8.856.